Brain Biotech Ag · XETR:BNN
Brain Biotech — Investor Day (February 2023)
16 slides from Brain Biotech's investor day presentation, Feb 27, 2023
Slide 1: BRAIN Biotech AG Capital Markets Day 2023
BRAIN Biotech AG Creating a #BiobasedFuture Capital Markets Day 2023 Zwingenberg, February 27, 2023 Since 2021 we have been committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, the environment and anti-corruption. Creating a #
Slide 2: Multi-Niche Enzyme Champion: One BioProducts
Capital Markets Day 2023 Creating a #BiobasedFuture Multi-Niche Enzyme Champion: One BioProducts Rod Sears Black, MD BioProducts Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg Germany www.brain-biotech.com +49 (0) 6251-9331-0 40
Slide 3: Merging BRAIN's Products businesses under the Biocatalysts roof
Merging BRAIN9s Products businesses under the Biocatalysts roof BRAIN BioProducts Division Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg Germany www.brain-biotech.com +49 (0) 6251-9331-0 41
Slide 4: What is a multi-niche company?
What is a multi-niche company? how to create real value upside Currently: BioIndustrial <house of brands= Adjacent sectors and/ geographies Very little overlap in product, sector and market Independently resourced Operating in defined niches, limited by sector, application and technology Fut
Slide 5: One BioProducts: the big goals
One BioProducts: the big goals why are we doing this and where are we going? Enzyme partner of choice €80m >20% sales by EBITDA 2028 Top 10 enzyme company Tier 1 Double the customer market base growth rate Discovery to formulation capability Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg
Slide 6: One BioProducts: The Structure
One BioProducts: The Structure clear responsibilities driven by an experienced international management team SVP Bioproducts Rod Sears-Black VP Finance Bioproducts Katy Penny BU Head NA BU Dir. Bakery and Operations Dir. BU Director Food and BU Dir. Fermented Flavour and Enzyme Beverage NK/BB Pharma
Slide 7: One BioProducts: Market sector driven
One BioProducts: Market sector driven focussed, P&L driven commercial set up and flexible manufacture SVP Bioproducts VP Finance Bioproducts BU Head NA BU Dir. Bakery and Operations Dir. BU Director Food and BU Dir. Fermentation Flavour and Enzyme Beverage NK/BB Pharma and Tech Dir. Divisional funct
Slide 8: Why (should) customers come to Biocatalysts
Why (should) customers come to Biocatalysts capability and partnership mindset Agile company with short communication lines and commercial and operational flexibility Focused on niches and happy to do so Foundation in BioScience: Full Biotech toolkit and end to end capability from Discovery to
Slide 9: Manufacturing footprint
Manufacturing footprint growing international manufacturing and distribution setup Nieuwkuijk Cardiff Tampa Büttelborn Dry blending Fermentation Liquid blending Numbers based on FY 2021/22 Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg Germany www.brain-biotech.com +49 (0) 6251-9331-0 47
Slide 10: Growth Initiatives under way
Growth Initiatives under way large scale fermentation expansion project and site expansion February 823 June 824 Biocatalysts – Cardiff <phase 3= development of new fermentation hall for 25m3 fermenters and automated liquid blending facility Future <people space= acquired summer 2022 Completion summ
Slide 11: Future Opportunities
Future Opportunities growth challenges to master Simplification and value add to all of our activities Elimination of duplication Planned investment programme, expand to include all site development activity, reconsider the footprint The aggressive plan for maximum growth Breatec expansion for the f
Slide 12: Accelerating Profitability in Manufacturing
Accelerating Profitability in Manufacturing clearly identified drivers Control of input costs – group purchasing initiatives Supplier and material rationalisation Fermentation expansion and management of processes Plant utilisation Improvements to yield and recovery Must do, every year Site simplifi
Slide 13: Scales of fermentation
Scales of fermentation a unique range of capabilities Multiple small scale fermenters from 50l and 750l fermenters with full range of 10m3 fermenter on site with plans for 250ml to 3 litre DSP including freeze drying and 25m3 and partner scale to >50m3, DSP chromatography purification capability inc
Slide 14: Breatec
Breatec baking centre of excellence and state of the art dry blending facility • Modern factory and offices • Great application facility – test bakery • Highly efficient blending • Advanced dust control, ready for future requirements • Capacity to grow and potential for expansion to adjacent space C
Slide 15: Biosun
Biosun base for expanded US operations • Good quality factory and offices • Temperature controlled storage • Liquid blending capability • Entry point to US for Biocats products and onward distribution partner • Legal entity in our main target market • Capacity to grow will be challenged by overall s
Slide 16: Critical Success Factors
Critical Success Factors we must deliver here Talent retention, development and attraction Innovation pipeline Key customer retention and acquisition of new ones Fermentation: Yields, capacity utilisation Maintain a solid core in blended enzymes, liquid and dry across all sites In-group